<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01410539</url>
  </required_header>
  <id_info>
    <org_study_id>MOST Study</org_study_id>
    <nct_id>NCT01410539</nct_id>
  </id_info>
  <brief_title>Mechanism Of Stent Thrombosis (MOST) Study</brief_title>
  <acronym>Most</acronym>
  <official_title>Mechanism Of Stent Thrombosis (MOST) Study, a Prospective Multicentre Non-randomized Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Careggi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Careggi Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to assess the pathophysiology of ST by studying the main procedural
      and anatomical factors involved in the genesis of ST such as those related to stent and the
      vascular wall, as well as to the individual platelet residual reactivity.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of uncovered stent struts</measure>
    <time_frame>After thrombectomy</time_frame>
    <description>The percentage of uncovered stent struts by OCT in patients with subacute stent thrombosis (either DES and BMS) and the percentage of uncovered stent struts in patients with late (after one month) and very late thrombosis of DES.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of malapposed stent struts</measure>
    <time_frame>After Thrombectomy</time_frame>
    <description>The percentage of malapposed stent struts by OCT in patients with subacute thrombosis of DES and BMS and the percentage of malapposed stent struts by OCT in patients with late and very late thrombosis of DES.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients with high residual platelet reactivity</measure>
    <time_frame>Baseline</time_frame>
    <description>The percentage of patients with residual platelet reactivity (RPR) to ADP and arachidonic acid identified by values ≥ 240 P2Y12 reaction units (PRU) and ≥ 550 aspirin reaction units (ARU), respectively,. during aspirin and clopidogrel therapy or in which one or both the antiplatelet drugs have been interrupted.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Coronary Artery</condition>
  <condition>Stent Thrombosis</condition>
  <condition>Platelet</condition>
  <condition>Thrombus</condition>
  <arm_group>
    <arm_group_label>Stent Thrombosis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consecutive patients with stent thrombosis with stent strut assessment by OCT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control subjects without stent thrombosis from the RHR OCT database</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OCT guided PCI</intervention_name>
    <description>OCT guided PCI. Only thrombectomy in case of negative OCT findings (other than uncovered struts).</description>
    <arm_group_label>Stent Thrombosis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>OCT guided medical therapy</intervention_name>
    <description>OCT guided medical therapy. Tailored antiplatelet therapy.</description>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  previous PCI with bare metal stent (BMS) or drug eluting stent (DES) and a definite
             subacute coronary ST

          -  previous PCI with DES and a definite late or very late coronary ST

        Exclusion Criteria:

          -  Development of ST within 72 hours of stent implantation (acute and early subacute ST).

          -  Late and very late ST of BMS.

          -  Absence of informed consent.

          -  Age less than 18 years.

          -  Creatinine values greater than 2.5 g/dl (this is to avoid the negative effects related
             to the contrast medium necessary to perform the OCT evaluation).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Antoniucci, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Careggi Hospital, Division of Invasive Cardiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francesco Prati, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rome Heart Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Careggi Hospital, Department of Hearth and Vessels</name>
      <address>
        <city>Florence</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 4, 2011</study_first_submitted>
  <study_first_submitted_qc>August 4, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 5, 2011</study_first_posted>
  <last_update_submitted>September 24, 2014</last_update_submitted>
  <last_update_submitted_qc>September 24, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 25, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Careggi Hospital</investigator_affiliation>
    <investigator_full_name>David Antoniucci</investigator_full_name>
    <investigator_title>Head Division of Invasive Cardiology</investigator_title>
  </responsible_party>
  <keyword>Stent Thrombosis</keyword>
  <keyword>Percutaneous Coronary Intervention</keyword>
  <keyword>Bare Metal Stent</keyword>
  <keyword>Drug Eluting Stent</keyword>
  <keyword>Residual Platelet Reactivity</keyword>
  <keyword>Optical Coherence Tomography</keyword>
  <keyword>OCT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

